LEIDEN, NETHERLANDS--(Marketwire - March 28, 2008) - Annual General Meeting and publication of 2007 annual report postponed OctoPlus N.V. (“OctoPlus” or the “Company”) (Euronext: OCTO), the drug delivery and development company, announces today that it has been granted a bridge financing of up to EUR 4 million from its existing shareholders Life Sciences Partners and SR One to enable the Company to secure one or more of the longer term financing options currently under negotiation.
